What Is Mifepristone, the Abortion Drug at Issue in the Hearing?
A key issue in the hearing has been whether Robert F. Kennedy Jr. would increase scrutiny of the abortion drug mifepristone if he becomes HHS secretary. The drug is part of a two-step process that is now the most common way to end a pregnancy in the U.
The New Republic on MSN1dOpinion
RFK Jr. Signals Trump’s Next Target in War Against AbortionRobert F. Kennedy Jr. made several disturbing comments during his first Senate confirmation hearing Wednesday suggesting that ...
A higher dose of an emergency-contraception drug may open a back door for Americans seeking abortions in restrictive states.
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...
Last Friday, my colleague Julianne McShane and I broke the news of a pair of letters sent by 30 prominent anti-abortion ...
Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.
A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?
Robert F. Kennedy Jr. suggested, if confirmed to head the Department of Health and Human Services, he is open to ...
Robert F. Kennedy Jr. will have the second of two confirmation hearings for his Health and Human Services Secretary nomination Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback